Stock ELN ELANIX BIOTECHNOLOGIES AG
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Elanix Biotechnologies AG Xetra

Equities

ELN

DE000A0WMJQ4

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Elanix Biotechnologies AG: RESIGNATION AND NOMINATION IN THE SUPERVISORY BOARD
EQ
Elanix Biotechnologies AG Announces Executive Changes
CI
Elanix Biotechnologies Ag Reports Earnings Results for the Half Year Ended June 30, 2019
CI
Elanix Biotechnologies AG: CRIMINAL CHARGES HAVE BEEN FILED AGAINST THE FORMER CEO THOMAS J. SVOBODA ALONG WITH FURTHER TWO SUSPECTED ACCOMPLICES
EQ
Anja Silling acquired 12.85% stake in Elanix Biotechnologies AG (DB:ELN) from Lee-Ann Laurent-Applegate for €1 million.
CI
18-04-2019Elanix Biotechnologies AG: NOMINATION OF THE CHAIRMAN OF THE SUPERVISORY BOARD, THE VICE CHAIRMAN AND MEMBERS OF THE BOARD.
PU
Elanix Biotechnologies AG: NOMINATION OF THE CHAIRMAN OF THE SUPERVISORY BOARD, THE VICE CHAIRMAN AND MEMBERS OF THE BOARD.
EQ
Elanix Biotechnologies Ag Announces Nomination of the Chairman of the Supervisory Board, the Vice Chairman and Members of the Board
CI
Elanix Biotechnologies AG Announces Resignation of Jürgen Kullmann from the Supervisory Board
CI
Elanix Biotechnologies AG Announces Change in Supervisory Board
CI
Elanix Plans To Sell Shares Of Company
CI
Elanix Biotechnologies AG (DB:ELN) cancelled the acquisition of Inno 4 Cell AG.
CI
Elanix Biotechnologies AG announced that it has received €0.870298 million in funding
CI
Elanix Biotechnologies AG Appoints Egon Minar to the Joint Role of Chief Operating Officer and Chief Financial Officer
CI
Elanix Biotechnologies AG announced that it expects to receive €0.870298 million in funding
CI
Elanix Biotechnologies AG signs an Agreement with MedBioSante
CI
Elanix Biotechnologies AG announced that it expects to receive €2.5 million in funding from Yorkville Advisors Global LP
CI
Elanix Biotechnologies AG announced that it expects to receive €11 million in funding
CI
Elanix Biotechnologies AG announced that it has received €1.125071 million in funding
CI
Elanix Biotechnologies AG announced a financing transaction
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ELN Stock
  4. ELN Stock
  5. News Elanix Biotechnologies AG